Global Disparities in Congenital Hyperinsulinism Care

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Public Health

Background:

• Hypoglycemia, particularly in infants and children, can lead to severe neurological damage and death.
• Congenital hyperinsulinism is a primary cause of persistent hypoglycemia in pediatric populations, increasing brain injury risk.
• Early and effective management of hypoglycemia is crucial for preventing long-term morbidity.

Purpose of the Study:

• To review and evaluate disparities in the screening, diagnosis, treatment, and longitudinal care of children with hypoglycemia, focusing on congenital hyperinsulinism.
• To highlight variations in access to essential healthcare services across different socioeconomic and geographic groups.

Main Methods:

• Literature review of studies examining hypoglycemia management in children.
• Analysis of disparities in access to screening, diagnostic tools, standard treatments, and specialist care.
• Focus on congenital hyperinsulinism as a model for evaluating care gaps.

Main Results:

• Significant variations exist in access to crucial diagnostic and screening tests for hypoglycemia.
• Disparities are evident in the availability and quality of standard-of-care treatments and specialist expertise.
• Socioeconomic and geographic factors profoundly influence the provision and outcomes of care for children with hypoglycemia.

Conclusions:

• Addressing disparities in screening, diagnosis, treatment, and ongoing care is essential to mitigate the risks of hypoglycemia-induced brain injury in children.
• Equitable access to comprehensive care for congenital hyperinsulinism and other causes of hypoglycemia is critical for improving pediatric outcomes.